‘Super weight loss’ drug retatrutide could be available soon
KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…
TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorder
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
Fiber Innovation Goes Mainstream as Brands Close the Nutrition Gap
According to FDA, the Daily Value for dietary fiber is 28g, based on a 2,000-calorie daily diet. However,…
FDA puts pharmacist on notice for selling unapproved weight-loss injections
SAN DIEGO, Calif. — A former Rancho Santa Fe pharmacist has agreed to stop selling unapproved weight-loss injections…
GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
GLP-1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a…
Protein craze can lead to better health if done right
It’s a question that Dr. Travis Wilkes gets asked every day by patients. It is something that Dr.…
GLP-1 Drugs May Be Quietly Changing How Americans Order Drinks
As GLP-1 use grows, clinical trials suggest semaglutide may reduce alcohol cravings and drinks per occasion, putting greater…
GLP-1 weight loss drugs linked to higher marriage and employment for some women
A recent study suggests GLP-1-related weight loss may improve some women’s relationships and employment status. Rebecca Diamond, professor of economics…
America’s GLP-1 use nearly quadruples in just two years
America is slimming down — one shot at a time. The number of US adults turning to blockbuster…
Ozempic, who? $10 fat-burning supplement goes viral on Amazon
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our…
GLP-1 trials reveal diet quality gap as companion products boom
Many GLP-1 clinical trials are not tracking what patients are consuming, pointing to a gap in the weight-loss…